Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.
PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.
CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.
Source: Read Full Article
Lates News:
-
Analyst Predicts Bitcoin to Hit $70,000+ Due to BlackRock and Federal Reserve
-
Cryptos Muted As Markets Guess The Fed's Monetary Policy Outlook
-
$BTC Is Up 25% Since Peter Schiff Said It Was ‘Time To Drop Bitcoin’
-
Cryptos Rise As Powell Sounds Less Hawkish Than Feared
-
Analytics Firm Santiment Highlights Market Fear as Potential Bitcoin Rebound Indicator